Annat Raiter

3PUBLICATIONS
2CO-AUTHORS
Molecular targetsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 18, 2023
TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor.

Annat Raiter, Julia Lipovetsky, Asaf Stenbac

|Jun 24, 2022
BNT162b2 Booster Vaccination Induced Immunity against SARS-CoV-2 Variants among Hemodialysis Patients.

Michal Herman-Edelstein, Naomi Ben-Dor, Timna Agur

|Jun 09, 2021
A novel role for an old target: CD45 for breast cancer immunotherapy.

Annat Raiter, Oran Zlotnik, Julia Lipovetsky

Pageof 1